121 related articles for article (PubMed ID: 15770694)
1. Selective inhibition of NF-kappaB in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization.
Tas SW; de Jong EC; Hajji N; May MJ; Ghosh S; Vervoordeldonk MJ; Tak PP
Eur J Immunol; 2005 Apr; 35(4):1164-74. PubMed ID: 15770694
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human dendritic cells by a novel specific nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Shinoda K; Nakagawa K; Kosaka T; Tanaka N; Maeda T; Kono H; Mizuno R; Kikuchi E; Miyajima A; Umezawa K; Oya M
Hum Immunol; 2010 Aug; 71(8):763-70. PubMed ID: 20573582
[TBL] [Abstract][Full Text] [Related]
3. A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells.
Wen D; Nong Y; Morgan JG; Gangurde P; Bielecki A; Dasilva J; Keaveney M; Cheng H; Fraser C; Schopf L; Hepperle M; Harriman G; Jaffee BD; Ocain TD; Xu Y
J Pharmacol Exp Ther; 2006 Jun; 317(3):989-1001. PubMed ID: 16525037
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of PI3-Kinase, MAPKs and NF-kappaB on the manipulation of dendritic cell T(h)1/T(h)2 cytokine/chemokine polarizing profile.
Neves BM; Cruz MT; Francisco V; Garcia-Rodriguez C; Silvestre R; Cordeiro-da-Silva A; Dinis AM; Batista MT; Duarte CB; Lopes MC
Mol Immunol; 2009 Aug; 46(13):2481-92. PubMed ID: 19520433
[TBL] [Abstract][Full Text] [Related]
5. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
6. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways.
Lin YL; Liang YC; Tseng YS; Huang HY; Chou SY; Hseu RS; Huang CT; Chiang BL
J Leukoc Biol; 2009 Oct; 86(4):877-89. PubMed ID: 19498044
[TBL] [Abstract][Full Text] [Related]
7. Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression.
Hegde S; Pahne J; Smola-Hess S
FASEB J; 2004 Sep; 18(12):1439-41. PubMed ID: 15247147
[TBL] [Abstract][Full Text] [Related]
8. 1,25-dihydroxyvitamin D3 induces biphasic NF-kappaB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IkappaB.
Tse AK; Wan CK; Shen XL; Zhu GY; Cheung HY; Yang M; Fong WF
Exp Cell Res; 2007 May; 313(8):1722-34. PubMed ID: 17397830
[TBL] [Abstract][Full Text] [Related]
9. NF-{kappa}B is required for STAT-4 expression during dendritic cell maturation.
Remoli ME; Ragimbeau J; Giacomini E; Gafa V; Severa M; Lande R; Pellegrini S; Coccia EM
J Leukoc Biol; 2007 Jan; 81(1):355-63. PubMed ID: 17046972
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
13. Coordinate NF-kappaB and STAT1 activation promotes development of myeloid type 1 dendritic cells.
Vakkila J; Demarco RA; Lotze MT
Scand J Immunol; 2008 Mar; 67(3):260-9. PubMed ID: 18261039
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cdelta and NF-kappaB pathway in human synovial fibroblasts.
Lee CH; Shieh DC; Tzeng CY; Chen CP; Wang SP; Chiu YC; Huang CY; Hsu CJ; Fong YC; Tang CH
Mol Immunol; 2008 Aug; 45(14):3693-702. PubMed ID: 18621420
[TBL] [Abstract][Full Text] [Related]
15. Targeted NF-kappaB inhibition of asthmatic serum-mediated human monocyte-derived dendritic cell differentiation in a transendothelial trafficking model.
Gu XY; Zhou LF; Zhang MS; Dai WJ; Chen SY; He SH; Ji XH; Yin KS
Cell Immunol; 2009; 260(1):14-20. PubMed ID: 19691956
[TBL] [Abstract][Full Text] [Related]
16. A nonredundant role for canonical NF-κB in human myeloid dendritic cell development and function.
van de Laar L; van den Bosch A; van der Kooij SW; Janssen HL; Coffer PJ; van Kooten C; Woltman AM
J Immunol; 2010 Dec; 185(12):7252-61. PubMed ID: 21076069
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of IKK activation, through sequestering NEMO, blocks PMMA-induced osteoclastogenesis and calvarial inflammatory osteolysis.
Clohisy JC; Yamanaka Y; Faccio R; Abu-Amer Y
J Orthop Res; 2006 Jul; 24(7):1358-65. PubMed ID: 16705717
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase C alpha, c-Src, NF-kappa B and p300 pathway.
Chiu YC; Fong YC; Lai CH; Hung CH; Hsu HC; Lee TS; Yang RS; Fu WM; Tang CH
Mol Immunol; 2008 Mar; 45(6):1587-99. PubMed ID: 18062909
[TBL] [Abstract][Full Text] [Related]
19. A new carboxamide compound exerts immuno-suppressive activity by inhibiting dendritic cell maturation.
Carbonnelle D; Ebstein F; Rabu C; Petit JY; Gregoire M; Lang F
Eur J Immunol; 2005 Feb; 35(2):546-56. PubMed ID: 15668915
[TBL] [Abstract][Full Text] [Related]
20. NEMO-binding domain peptide inhibits proliferation of human melanoma cells.
Ianaro A; Tersigni M; Belardo G; Di Martino S; Napolitano M; Palmieri G; Sini M; De Maio A; Ombra M; Gentilcore G; Capone M; Ascierto M; Satriano RA; Farina B; Faraone-Mennella M; Ascierto PA; Ialenti A
Cancer Lett; 2009 Feb; 274(2):331-6. PubMed ID: 19004544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
